Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Dec 3, 2020
Date Accepted: Apr 9, 2021

The final, peer-reviewed published version of this preprint can be found here:

A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study

Chai P, Bustamante MJ, Goodman G, Mohamed Y, Najarro J, Sullivan MC, Castillo-Mancilla J, Cole RP, Mayer KH, Rosen RK, Baumgartner SL, Alpert PE, Boyer EW, O'Cleirigh C

A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study

JMIR Form Res 2021;5(4):e26213

DOI: 10.2196/26213

PMID: 33890863

PMCID: 8105755

A brief training program to support use of a digital pill system for medication adherence: a developmental study

  • Peter Chai; 
  • Majo J Bustamante; 
  • Georgia Goodman; 
  • Yassir Mohamed; 
  • Jesse Najarro; 
  • Matthew C Sullivan; 
  • Jose Castillo-Mancilla; 
  • Ryan P Cole; 
  • Kenneth H Mayer; 
  • Rochelle K Rosen; 
  • Susan L Baumgartner; 
  • Pamela E Alpert; 
  • Edward W Boyer; 
  • Conall O'Cleirigh

ABSTRACT

Background:

Digital pill systems (DPS), which comprise ingestible radiofrequency sensors integrated into a gelatin capsule that overencapsulates a medication, can directly measure ingestion events.

Objective:

Teaching users to operate a DPS is vital to ensuring the collection of actionable ingestion and adherence data. We developed and piloted a training program, grounded in the Technology Acceptance Model (TAM), to instruct individuals on DPS operation.

Methods:

A two-part training program, comprising in-person and text message-based components, was employed with HIV-negative men who have sex with men (MSM) with non-alcohol substance use, who had enrolled in a 90-day pilot demonstration study using the DPS to measure adherence to pre-exposure prophylaxis (PrEP). We assessed the number of responses to text check-ins, the number and types of episodes where technical support was requested, and the resolutions of such issues. Finally, we measured engagement with the program over the study period.

Results:

Fifteen participants were enrolled in and completed the program. Seven technical challenges were reported across five participants and were related to DPS operation. Most commonly, participants requested support connecting the wearable Reader device with their smartphone, charging the Reader, and problems operating the mobile application. Six of these issues were resolved asynchronously or in real-time over the phone. One issue required in-person evaluation and resolution.

Conclusions:

A brief, two-part DPS training program, drawing from individuals’ experiences and from the TAM, can provide valuable insights for users. This training program also captures several areas of difficulty related to operating the DPS and allows for resolution of these issues. Clinical Trial: NCT03842436


 Citation

Please cite as:

Chai P, Bustamante MJ, Goodman G, Mohamed Y, Najarro J, Sullivan MC, Castillo-Mancilla J, Cole RP, Mayer KH, Rosen RK, Baumgartner SL, Alpert PE, Boyer EW, O'Cleirigh C

A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study

JMIR Form Res 2021;5(4):e26213

DOI: 10.2196/26213

PMID: 33890863

PMCID: 8105755

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.